Early Warning for Cardiovascular Risk

The EndoPat test measures endothelial function by detecting blood flow changes in your fingertips, offering an early warning of cardiovascular risk through the health of your blood vessel linings. It works by placing biosensors on your index fingers and inflating a blood pressure cuff on one arm to temporarily block and then release blood flow, calculating a Reactive Hyperemia Index (RHI) or EndoScore that reflects how well your endothelium responds; low scores signal dysfunction linked to atherosclerosis. Providing data of subclinical vascular damage years before symptoms arise, empowering you to adjust lifestyle or treatment to prevent heart attacks or strokes, with precision validated by studies like those from the Mayo Clinic showing a 300% higher cardiac event risk for poor scorers.